phagos

phagos

Recherche en biotechnologie

Suresnes, Île-de-France 3 635 abonnés

Unleash Bacteriophage Potential

À propos

We founded Phagos out of a common ideal: to use entrepreneurship as a force for positive change. Antibiotic resistance is an urgent and unaddressed global challenge that was declared a top 10 threat to humanity by the World Health Organisation. Experts project that this 'silent pandemic' could kill 10 million people per year by 2050. At Phagos, we're dedicated to finding a solution. Our approach is evolutionary—we harness the natural predator of bacteria, the bacteriophage, to cure these life-threatening infectious diseases. Bacteriophages can become an efficient and sustainable alternative to antibiotics. But this is just a fraction of their potential. Embark on the journey with us! Unleash Bacteriophage Potential

Secteur
Recherche en biotechnologie
Taille de l’entreprise
11-50 employés
Siège social
Suresnes, Île-de-France
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2021
Domaines
Phage Therapy, Biomimetics et Animal Health

Lieux

Employés chez phagos

Nouvelles

Pages similaires

Parcourir les offres d’emploi

Financement

phagos 5 rounds en tout

Dernier round

Subside

1 470 082,00 $US

Investisseurs

Bpifrance
Voir plus d’informations sur Crunchbase